LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus-Reference-Cited by-同舟云学术

LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus

Published:2018-04-16 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Cobo-Vuilleumier Nadia,Lorenzo Petra I.,Rodríguez Noelia García,Herrera Gómez Irene de Gracia,Fuente-Martin Esther,López-Noriega Livia,Mellado-Gil José Manuel,Romero-Zerbo Silvana-Yanina,Baquié Mathurin,Lachaud Christian Claude,Stifter Katja,Perdomo German,Bugliani Marco,De Tata Vincenzo,Bosco Domenico,Parnaud Geraldine,Pozo David^ORCID,Hmadcha Abdelkrim^ORCID,Florido Javier P.,Toscano Miguel G.,de Haan Peter,Schoonjans Kristina,Sánchez Palazón Luis,Marchetti Piero,Schirmbeck Reinhold,Martín-Montalvo Alejandro,Meda Paolo,Soria Bernat,Bermúdez-Silva Francisco-Javier^ORCID,St-Onge Luc,Gauthier Benoit R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-03943-0.pdf

Reference66 articles.

1. Pociot, F. & Lernmark, A. Genetic risk factors for type 1 diabetes. Lancet 387, 2331–2339 (2016).

2. Rewers, M. & Ludvigsson, J. Environmental risk factors for type 1 diabetes. Lancet 387, 2340–2348 (2016).

3. Vudattu, N. K. & Herold, K. C. Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in development. Expert. Opin. Biol. Ther. 14, 377–385 (2014).

4. Moran, A. et al. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381, 1905–1915 (2013).

5. Sherry, N. A. et al. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55, 3238–3245 (2006).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilirubin is a new ligand for nuclear receptor Liver Receptor Homolog-1;2024-05-06

2. Liver receptor homolog-1: structures, related diseases, and drug discovery;Acta Pharmacologica Sinica;2024-04-17

3. Liver receptor homolog-1 (NR5A2) orchestrates hepatic inflammation and TNF-induced cell death;Cell Reports;2023-12

4. PPARs at the crossroads of T cell differentiation and type 1 diabetes;Frontiers in Immunology;2023-10-20

5. LRH-1/NR5A2 Activation in Immune Cells from Individuals with Type 1 Diabetes Mellitus Mitigates Inflammation via Immunometabolic Reprogramming and Enhanced Human Islet Function in Mice;2023-09-18